Pharmaceutical CDMO and Generics Manufacturer.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | SALT POINT STRATEGIES |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | SALT POINT STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | SALT POINT STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | SALT POINT STRATEGIES |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| SALT POINT STRATEGIES | 4 | — |
| Issue | Activities |
|---|---|
| Tariff (miscellaneous tariff bills) | 4 |
| Trade (domestic/foreign) | 4 |
| Manufacturing | 4 |